Evidence map›Paper›PMID 39788521›Full record

ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2024

Multidisciplinary integration and fusion based on critical care medicine and immunology: History, current status, and prospects.

Jian Shi, Ben Lü

Abstract readReview
In one paragraph

Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jian ShiThird Xiangya Hospital, Central South University, Changsha 410013. xyshijian@csu.edu.cn.
Ben LüThird Xiangya Hospital, Central South University, Changsha 410013. xybenlu@csu.edu.cn.

Funding

the National Science Foundation for Distinguished Young Scholars, China 82025021This is an open access article under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International //creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>)
6 · The paper itself

Abstract

Critical care medicine focuses on understanding the pathophysiological mechanisms and treatment approaches for life-threatening conditions, including sepsis, severe trauma/burns, hemorrhagic shock, heatstroke, and acute pancreatitis, all of which have high incidence rates. These conditions are primarily characterized by acute multi-organ dysfunction, with sudden onset, severe illness, and high mortality rates. Additionally, critical care treatment demands substantial medical resources, imposing significant economic burdens on patients' families and society. In recent years, critical care medicine has achieved notable progress, especially in multidisciplinary integration with immunology-based fields. Collaboration across disciplines has not only accelerated advancements in critical care but also propelled the rapid development of modern immunology. This paper provides an overview and assessment of the cross-disciplinary fusion between critical care medicine and immunology, exploring how these fields related extensions mutually enhance each other. It further analyzes China's potential to become a global leader in this area within the next 5 to 10 years.

Indexed as

Allergy and ImmunologyCritical CareChinaHumansInterdisciplinary Communicationcritical care medicinecross-disciplinary integrationimmunologyintensive caremultidisciplinarysepsis

Identifiers

PMID39788521
PMCPMC11628226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.